Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Steven Takemoto, PhD

    TitleAssociate Professor
    SchoolUCSF School of Medicine
    DepartmentAnesthesia/Perioperative Care
    Address4150 Clement Street, VAMC 129
    San Francisco CA 94121
    Phone415-221-4810x3116

       Overview 
       Overview
      My primary interest is setting up integrated data repositories that can be used to assess and report quality of care outcomes to condition/procedure specific registries. The goal of this activity is to minimize the effort required for registry reporting by utilizing existing data streams and developing methods for capturing data while improving the delivery of clinical care. Working closely with the medical center Orthopaedic surgery service line administrator we developed an integrated data repository (IDR) where an ontology derives terms used by physicians and patients to describe risk factors, surgical parameters and outcomes from diagnosis and procedure codes routinely generated in hospital and physician claims. We recently used data derived from this IDR to respond to Blue-Cross Blue Shield Center of Excellence surveys for hip and knee replacement and spine surgery. We are currently in the process of overcoming regulatory barriers to replicate this IDR at other medical school campuses.

      Working with a mobile health startup, Pipette, we were recently awarded a REAC mobile health research award to pilot a mobile phone application that sends patients 10 questions daily for the 14 days after they receive a hip or knee replacement. These questions will help Orthopaedic surgery residents to assess whether patients are experiencing infectious, thrombotic, pain or gastrointestinal complications, and provide data that will be helpful for assessing the clinical success of the operation.

      We have applied the ontology to Medicare, private payer and the national inpatient sample to describe trends in Orthopaedic surgery and have developed algorithms that distinguish planned from unplanned readmissions.


       ORNG Applications 
       In The News
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Abdul-Jabbar A, Berven SH, Hu SS, Chou D, Mummaneni PV, Takemoto S, Ames C, Deviren V, Tay B, Weinstein P, Burch S, Liu C. Surgical site infections in spine surgery: identification of microbiologic and surgical characteristics in 239 cases. Spine (Phila Pa 1976). 2013 Oct 15; 38(22):E1425-31.
        View in: PubMed
      2. Schamber EM, Takemoto SK, Chenok KE, Bozic KJ. Barriers to completion of Patient Reported Outcome Measures. J Arthroplasty. 2013 Oct; 28(9):1449-53.
        View in: PubMed
      3. Lin CA, Kuo AC, Takemoto S. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2013 Jun 5; 95(11):1028-36.
        View in: PubMed
      4. Modhia U, Takemoto S, Braid-Forbes MJ, Weber M, Berven SH. Readmission rates after decompression surgery in patients with lumbar spinal stenosis among Medicare beneficiaries. Spine (Phila Pa 1976). 2013 Apr 1; 38(7):591-6.
        View in: PubMed
      5. Barnes CL, Vail TP, Takemoto SK. Where do knee revisions for infection, fracture, and other revisions get treated? J Arthroplasty. 2013 Mar; 28(3):423-8.
        View in: PubMed
      6. Amin BY, Tu TH, Schairer WW, Na L, Takemoto S, Berven S, Deviren V, Ames C, Chou D, Mummaneni PV. Pitfalls of calculating hospital readmission rates based on nonvalidated administrative data sets: : presented at the 2012 Joint Spine Section Meeting: clinical article. J Neurosurg Spine. 2013 Feb; 18(2):134-8.
        View in: PubMed
      7. Abdul-Jabbar A, Takemoto S, Weber MH, Hu SS, Mummaneni PV, Deviren V, Ames CP, Chou D, Weinstein PR, Burch S, Berven SH. Surgical site infection in spinal surgery: description of surgical and patient-based risk factors for postoperative infection using administrative claims data. Spine (Phila Pa 1976). 2012 Jul 1; 37(15):1340-5.
        View in: PubMed
      8. Worni M, Pietrobon R, Zammar GR, Shah J, Yoo B, Maldonato M, Takemoto S, Vail TP. System dynamics to model the unintended consequences of denying payment for venous thromboembolism after total knee arthroplasty. PLoS One. 2012; 7(4):e30578.
        View in: PubMed
      9. Indrakanti SS, Weber MH, Takemoto SK, Hu SS, Polly D, Berven SH. Value-based care in the management of spinal disorders: a systematic review of cost-utility analysis. Clin Orthop Relat Res. 2012 Apr; 470(4):1106-23.
        View in: PubMed
      10. Saadat E, Diekmann G, Takemoto S, Ries MD. Is an algorithmic approach to the treatment of recurrent dislocation after THA effective? Clin Orthop Relat Res. 2012 Feb; 470(2):482-9.
        View in: PubMed
      11. Bozic KJ, Chiu VW, Takemoto SK, Greenbaum JN, Smith TM, Jerabek SA, Berry DJ. The validity of using administrative claims data in total joint arthroplasty outcomes research. J Arthroplasty. 2010 Sep; 25(6 Suppl):58-61.
        View in: PubMed
      12. Ward DT, Hansen EN, Takemoto SK, Bozic KJ. Cost and effectiveness of postoperative fever diagnostic evaluation in total joint arthroplasty patients. J Arthroplasty. 2010 Sep; 25(6 Suppl):43-8.
        View in: PubMed
      13. Halloran DR, Swindle J, Takemoto SK, Schnitzler MA. Multiple psychiatric diagnoses common in privately insured children on atypical antipsychotics. Clin Pediatr (Phila). 2010 May; 49(5):485-90.
        View in: PubMed
      14. Luke AC, Stehling C, Stahl R, Li X, Kay T, Takamoto S, Ma B, Majumdar S, Link T. . Am J Sports Med. High-field magnetic resonance imaging assessment of articular cartilage before and after marathon running: does long-distance running lead to cartilage damage?. 2010; 11(38):2273-80.
      15. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009 Nov; 9(11):2597-606.
        View in: PubMed
      16. Salvalaggio PR, Graff RJ, Pinsky B, Schnitzler MA, Takemoto SK, Burroughs TE, Santos LS, Lentine KL. Crossmatch testing in kidney transplantation: patterns of practice and associations with rejection and graft survival. Saudi J Kidney Dis Transpl. 2009 Jul; 20(4):577-89.
        View in: PubMed
      17. Gill J, Shah T, Hristea I, Chavalitdhamrong D, Anastasi B, Takemoto SK, Bunnapradist S. Outcomes of simultaneous heart-kidney transplant in the US: a retrospective analysis using OPTN/UNOS data. Am J Transplant. 2009 Apr; 9(4):844-52.
        View in: PubMed
      18. Young BY, Gill J, Huang E, Takemoto SK, Anastasi B, Shah T, Bunnapradist S. Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol. 2009 Apr; 4(4):845-52.
        View in: PubMed
      19. Shah T, Gill J, Malhotra N, Takemoto SK, Bunnapradist S. Kidney transplant outcomes in patients with Fabry disease. Transplantation. 2009 Jan 27; 87(2):280-5.
        View in: PubMed
      20. Machnicki G, Pinsky B, Takemoto S, Balshaw R, Salvalaggio PR, Buchanan PM, Irish W, Bunnapradist S, Lentine KL, Burroughs TE, Brennan DC, Schnitzler MA. Predictive ability of pretransplant comorbidities to predict long-term graft loss and death. Am J Transplant. 2009 Mar; 9(3):494-505.
        View in: PubMed
      21. Shah T, Bunnapradist S, Hutchinson I, Pravica V, Cho YW, Mendez R, Mendez R, Takemoto SK. The evolving notion of "senior" kidney transplant recipients. Clin Transplant. 2008 Nov-Dec; 22(6):794-802.
        View in: PubMed
      22. Takemoto SK, Arns W, Bunnapradist S, Garrison LP, Guirado L, Kalo Z, Oniscu G, Opelz G, Scolari MP, Stefoni S, Yaqoob M, Brennan DC. Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation. 2008 Jul 15; 86(1):18-25.
        View in: PubMed
      23. Chavalitdhamrong D, Gill J, Takemoto S, Madhira BR, Cho YW, Shah T, Bunnapradist S. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database. Transplantation. 2008 Jun 15; 85(11):1573-9.
        View in: PubMed
      24. Bunnapradist S, Neri L, Wong W, Lentine KL, Burroughs TE, Pinsky BW, Takemoto SK, Schnitzler MA. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis. 2008 Mar; 51(3):478-86.
        View in: PubMed
      25. Neri L, Rocca Rey LA, Pinsky BW, Lentine KL, Salvalaggio PR, Machnicki G, Willoughby L, Burroughs TE, Takemoto SK, Schnitzler MA. Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease. Transplantation. 2008 Feb 15; 85(3):344-52.
        View in: PubMed
      26. Philipneri MD, Rocca Rey LA, Schnitzler MA, Abbott KC, Brennan DC, Takemoto SK, Buchanan PM, Burroughs TE, Willoughby LM, Lentine KL. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol. 2008 Feb; 12(1):41-52.
        View in: PubMed
      27. Takemoto SK, Pinsky BW, Schnitzler MA, Lentine KL, Willoughby LM, Burroughs TE, Bunnapradist S. A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant. 2007 Dec; 7(12):2704-11.
        View in: PubMed
      28. Shaker M, Lobb A, Jenkins P, O'Rourke D, Takemoto SK, Sheth S, Burroughs T, Dykewicz MS. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2008 Jan; 121(1):81-7.
        View in: PubMed
      29. Salvalaggio PR, Schnitzler MA, Abbott KC, Brennan DC, Irish W, Takemoto SK, Axelrod D, Santos LS, Kocak B, Willoughby L, Lentine KL. Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors. Am J Transplant. 2007 Jun; 7(6):1561-71.
        View in: PubMed
      30. Burroughs TE, Swindle J, Takemoto S, Lentine KL, Machnicki G, Irish WD, Brennan DC, Schnitzler MA. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 2007 Apr 27; 83(8):1027-34.
        View in: PubMed
      31. Aydingoz SE, Takemoto SK, Pinsky BW, Salvalaggio PR, Lentine KL, Willoughby L, Hoover B, Burroughs TA, Schnitzler MA, Graff R. The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage. Hum Immunol. 2007 Jun; 68(6):491-9.
        View in: PubMed
      32. Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clin J Am Soc Nephrol. 2007 May; 2(3):517-23.
        View in: PubMed
      33. Willoughby LM, Fukami S, Bunnapradist S, Gavard JA, Lentine KL, Hardinger KL, Burroughs TE, Takemoto SK, Schnitzler MA. Health insurance considerations for adolescent transplant recipients as they transition to adulthood. Pediatr Transplant. 2007 Mar; 11(2):127-31.
        View in: PubMed
      34. Schnitzler MA, Salvalaggio PR, Axelrod DA, Lentine KL, Takemoto SK. Lack of interventional studies in renal transplant candidates with elevated cardiovascular risk. Am J Transplant. 2007 Mar; 7(3):493-4.
        View in: PubMed
      35. Wade JA, Hurley CK, Takemoto SK, Thompson J, Davies SM, Fuller TC, Rodey G, Confer DL, Noreen H, Haagenson M, Kan F, Klein J, Eapen M, Spellman S, Kollman C. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood. 2007 May 1; 109(9):4064-70.
        View in: PubMed
      36. Bunnapradist S, Chung P, Peng A, Hong A, Chung P, Lee B, Fukami S, Takemoto SK, Singh AK. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation. 2006 Sep 15; 82(5):612-8.
        View in: PubMed
      37. Stirnemann PM, Takemoto SK, Schnitzler MA, Brennan DC, Abbott KC, Salvalaggio P, Burroughs TE, Gavard JA, Willoughby LM, Lentine KL. Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol. 2006 Aug; 17(8):2299-306.
        View in: PubMed
      38. Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant. 2006 Apr; 25(4):434-9.
        View in: PubMed
      39. Lentine KL, Schnitzler MA, Abbott KC, Li L, Xiao H, Burroughs TE, Takemoto SK, Willoughby LM, Gavard JA, Brennan DC. Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol. 2006 Mar; 1(2):288-96.
        View in: PubMed
      40. Bunnapradist S, Takemoto SK. Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplants. Transplant Proc. 2005 Mar; 37(2):889-91.
        View in: PubMed
      41. Bunnapradist S, Hong A, Lee B, Takemoto SK. Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches. Transplant Proc. 2005 Mar; 37(2):886-8.
        View in: PubMed
      42. Machnicki G, Pinsky B, Takemoto S, Lentine K, Willoughby L, Bunnapradist S, Burroughs T, Schnitzler MA. Application of diagnostic classification algorithms to identify the most common causes of post-transplant complications. Clin Transpl. 2005; 57-67.
        View in: PubMed
      43. Takemoto S, Port FK, Claas FH, Duquesnoy RJ. HLA matching for kidney transplantation. Hum Immunol. 2004 Dec; 65(12):1489-505.
        View in: PubMed
      44. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004 Jul; 4(7):1033-41.
        View in: PubMed
      45. Bunnapradist S, Takemoto SK. Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors. Transplant Proc. 2003 Nov; 35(7):2407-8.
        View in: PubMed
      46. Alloway RR, Isaacs R, Lake K, Hoyer P, First R, Helderman H, Bunnapradist S, Leichtman A, Bennett MW, Tejani A, Takemoto SK. Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants. Am J Transplant. 2003 Oct; 3(10):1211-5.
        View in: PubMed
      47. Bunnapradist S, Daswani A, Takemoto SK. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. Transplantation. 2003 Jul 15; 76(1):10-5.
        View in: PubMed
      48. Duquesnoy RJ, Howe J, Takemoto S. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Transplantation. 2003 Mar 27; 75(6):889-97.
        View in: PubMed
      49. Duquesnoy RJ, Takemoto S, de Lange P, Doxiadis II, Schreuder GM, Persijn GG, Claas FH. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation. 2003 Mar 27; 75(6):884-9.
        View in: PubMed
      50. Helderman JH, Bennett WM, Cibrik DM, Kaufman DB, Klein A, Takemoto SK. Immunosuppression: practice and trends. Am J Transplant. 2003; 3 Suppl 4:41-52.
        View in: PubMed
      51. Takemoto SK. HLA matching in the new millennium. Clin Transpl. 2003; 387-403.
        View in: PubMed
      52. Bunnapradist S, Takemoto SK. Multivariate analyses of antibody induction therapies. Clin Transpl. 2003; 405-17.
        View in: PubMed
      53. Michaels PJ, Espejo ML, Kobashigawa J, Alejos JC, Burch C, Takemoto S, Reed EF, Fishbein MC. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003 Jan; 22(1):58-69.
        View in: PubMed
      54. Lee PC, Terasaki PI, Takemoto SK, Lee PH, Hung CJ, Chen YL, Tsai A, Lei HY. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation. 2002 Oct 27; 74(8):1192-4.
        View in: PubMed
      55. Takemoto S. Patterns and outcomes for maintenance immunosuppression in the UNOS renal transplant registry. Transplant Proc. 2002 Aug; 34(5):1632-4.
        View in: PubMed
      56. Cecka JM, Takemoto SK, Gjertson DW. Putting one objection to HLA matching on ice. Am J Transplant. 2002 Apr; 2(4):295-6.
        View in: PubMed
      57. Bunnapradist S, Daswani A, Takemoto SK. Patterns of administration of antibody induction therapy and their associated outcomes. Clin Transpl. 2002; 351-8.
        View in: PubMed
      58. Takemoto SK, Bradley BA, Gjertson DW, Cho YW, Cecka JM. Pregnancy: a two-edged sword. Transplant Proc. 2001 Feb-Mar; 33(1-2):471-2.
        View in: PubMed
      59. Bradley BA, Takemoto S, Gjertson D, Reed E, Cecka M. Elderly transplant recipients may require less immunosuppression. Transplant Proc. 2001 Feb-Mar; 33(1-2):1115-6.
        View in: PubMed
      60. Takemoto SK. Maintenance immunosuppression. Clin Transpl. 2001; 223-36.
        View in: PubMed
      61. Tambur AR, Bray RA, Takemoto SK, Mancini M, Costanzo MR, Kobashigawa JA, D'Amico CL, Kanter KR, Berg A, Vega JD, Smith AL, Roggero AL, Ortegel JW, Wilmoth-Hosey L, Cecka JM, Gebel HM. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation. 2000 Oct 15; 70(7):1055-9.
        View in: PubMed
      62. Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med. 2000 Oct 12; 343(15):1078-84.
        View in: PubMed
      63. Lee PC, Lee PH, Shaw CK, Lei HY, Chen JC, Takemoto S. Effectiveness of an organ-sharing program in providing zero HLA-A,B,DR mismatched kidneys for transplantation in Taiwan. J Formos Med Assoc. 2000 Jun; 99(6):447-52.
        View in: PubMed
      64. Thompson JS, Thacker LR, Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry. Transplantation. 2000 May 27; 69(10):2178-86.
        View in: PubMed
      65. McKenna RM, Takemoto SK. Improving HLA matching for kidney transplantation by use of CREGs. Lancet. 2000 May 27; 355(9218):1842-3.
        View in: PubMed
      66. Takemoto SK, Cecka JM, Gjertson DW. The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med. 2000 Mar 16; 342(11):820-1.
        View in: PubMed
      67. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation. 2000 Feb 15; 69(3):319-26.
        View in: PubMed
      68. Takemoto SK. Maintenance immunosuppression. Clin Transpl. 2000; 481-95.
        View in: PubMed
      69. Takemoto SK, Cecka JM, Gjertson DW, Terasaki PI. Class I peptides involved in the indirect pathway of allorecognition. Transplant Proc. 1999 Feb-Mar; 31(1-2):781.
        View in: PubMed
      70. Terasaki P, Takemoto S. Impact of HLA system on organ transplantation: a critical review before the end of the millennium. Adv Nephrol Necker Hosp. 1999; 29:163-75.
        View in: PubMed
      71. Takemoto SK, Cho YW, Gjertson DW. Transplant risks. Clin Transpl. 1999; 325-34.
        View in: PubMed
      72. Lee PC, Lee PH, Shaw CK, Takemoto SK, Gjertson DW, Siauw PA, Terasaki PI. HLA epitopes for kidney allocation. Transplant Proc. 1998 Nov; 30(7):3496-7.
        View in: PubMed
      73. Hata Y, Cecka JM, Takemoto S, Ozawa M, Cho YW, Terasaki PI. Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients. Transplantation. 1998 Jan 27; 65(2):208-12.
        View in: PubMed
      74. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants. Clin Transplant. 1997 Oct; 11(5 Pt 1):366-72.
        View in: PubMed
      75. Takemoto SK, Terasaki PI. Evaluation of the transplant recipient and donor: molecular approach to tissue typing, flow cytometry and alternative approaches to distributing organs. Curr Opin Nephrol Hypertens. 1997 May; 6(3):299-303.
        View in: PubMed
      76. Gjertson DW, Terasaki PI, Cecka JM, Takemoto S, Cho YW. Senior citizens pool for aged kidneys. Transplant Proc. 1997 Feb-Mar; 29(1-2):129.
        View in: PubMed
      77. Cho YW, Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. Should excessive height and weight differences between the kidney donor and recipient be avoided? Transplant Proc. 1997 Feb-Mar; 29(1-2):104-5.
        View in: PubMed
      78. Takemoto SK, Cecka JM, Terasaki PI. Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts. Transplant Proc. 1997 Feb-Mar; 29(1-2):1417.
        View in: PubMed
      79. Thompson J, Thacker L, Takemoto S. CREG matching for first kidney transplants performed by SEOPF Centers between October 1987 and September 1995: an analysis of outcome and prospective benefit. Southeastern Procurement Foundation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1435-8.
        View in: PubMed
      80. Takemoto SK. Class I peptides involved in the indirect pathway of allorecognition. Clin Transpl. 1997; 317-35.
        View in: PubMed
      81. Terasaki P, Cecka M, Gjertson D, Takemoto S. Allocation of cadaver kidneys. Lancet. 1996 Nov 2; 348(9036):1247.
        View in: PubMed
      82. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S. Fit and match hypothesis for kidney transplantation. Transplantation. 1996 Aug 27; 62(4):441-5.
        View in: PubMed
      83. Takemoto S, Terasaki PI. HLA compatibility can be predicted by matching only three residues with outward oriented sidechains. Transplant Proc. 1996 Jun; 28(3):1264-6.
        View in: PubMed
      84. Terasaki PI, Cho Y, Takemoto S, Cecka M, Gjertson D. Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival. Transplant Proc. 1996 Jun; 28(3):1144-5.
        View in: PubMed
      85. Terasaki PL, Cecka JM, Gjertson DW, Takemoto S, Cho YW. Organizing a living donor pool: could the concept work? Nephrol News Issues. 1996 Feb; 10(2):37-8.
        View in: PubMed
      86. Takemoto SK. HLA amino acid residue matching. Clin Transpl. 1996; 397-425.
        View in: PubMed
      87. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S, Cho YW, Yuge J. Risk rate and long-term kidney transplant survival. Clin Transpl. 1996; 443-58.
        View in: PubMed
      88. Hata Y, Ozawa M, Takemoto SK, Cecka JM. HLA matching. Clin Transpl. 1996; 381-96.
        View in: PubMed
      89. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995 Aug 10; 333(6):333-6.
        View in: PubMed
      90. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S. Proposed HLA matching scheme for improved cadaveric kidney allocation. Transplant Proc. 1995 Feb; 27(1):61-3.
        View in: PubMed
      91. Takemoto S, Gjertson DW, Cecka JM, Terasaki PI. HLA matching for local pools using fewer HLA factors. Transplant Proc. 1995 Feb; 27(1):675-7.
        View in: PubMed
      92. Gjertson DW, Takemoto S, Cecka JM, Terasaki PI. Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching. Transplant Proc. 1995 Feb; 27(1):653-5.
        View in: PubMed
      93. Marcove RC, Sheth DS, Takemoto S, Healey JH. The treatment of aneurysmal bone cyst. Clin Orthop Relat Res. 1995 Feb; (311):157-63.
        View in: PubMed
      94. Wolf JS, Callender CO, Terasaki PI, Cecka JM, Gjertson DW, Takemoto SK. How should cadaver-donor kidneys be allocated in the United States? Clin Transpl. 1995; 351-61.
        View in: PubMed
      95. Takemoto S. Sensitization and crossmatch. Clin Transpl. 1995; 417-32.
        View in: PubMed
      96. Terasaki PI, McClelland JD, Yuge J, Cecka JM, Gjertson DW, Takemoto S, Cho YW. Advances in kidney transplantation: 1985-1995. Clin Transpl. 1995; 487-501.
        View in: PubMed
      97. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S. HLA matching for improved cadaver kidney allocation. Curr Opin Nephrol Hypertens. 1994 Nov; 3(6):585-8.
        View in: PubMed
      98. Takemoto S, Terasaki PI, Gjertson DW, Cecka JM. Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med. 1994 Sep 22; 331(12):760-4.
        View in: PubMed
      99. Takemoto S, Terasaki PI. Comparison of HLA matching protocols to maximize the number of compatible kidney recipients in small Asian pools. Transplant Proc. 1994 Aug; 26(4):1879-80.
        View in: PubMed
      100. Takemoto S, Terasaki PI. Refinement of permissible HLA mismatches. Clin Transpl. 1994; 451-66.
        View in: PubMed
      101. Takemoto S, Cecka JM, Gjertson DW, Terasaki PI. Six-antigen-matched transplants. Causes of failure. Transplantation. 1993 May; 55(5):1005-8.
        View in: PubMed
      102. Gjertson DW, Terasaki PI, Cecka JM, Takemoto S. Reduction of the center effect by HLA matching. Transplant Proc. 1993 Feb; 25(1 Pt 1):215-6.
        View in: PubMed
      103. Ogura K, Koyama H, Takemoto S, Chia J, Johnson C, Terasaki PI. Flow cytometry crossmatching for kidney transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 1):245-6.
        View in: PubMed
      104. Takemoto S, Terasaki PI, Maruya E, Park MS. Molecular matching for clinical kidney transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 1):206.
        View in: PubMed
      105. Takemoto S, Gjertson DW, Terasaki PI. HLA matching: maximizing the number of compatible transplants. Clin Transpl. 1993; 521-31.
        View in: PubMed
      106. Maruya E, Takemoto S, Terasaki PI. HLA matching: identification of permissible HLA mismatches. Clin Transpl. 1993; 511-20.
        View in: PubMed
      107. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. The role of HLA typing in clinical kidney transplants: 30 years later. Indisputable fact regarding clinical organ transplantation. Clin Transpl. 1993; 442-3.
        View in: PubMed
      108. Terasaki PI, Yuge J, Cecka JM, Gjertson DW, Takemoto S, Cho Y. Thirty-year trends in clinical kidney transplantation. Clin Transpl. 1993; 553-62.
        View in: PubMed
      109. Terasaki PI, Takemoto S, Park MS, Clark B. Landsteiner Award. HLA epitope matching. Transfusion. 1992 Oct; 32(8):775-86.
        View in: PubMed
      110. Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med. 1992 Sep 17; 327(12):834-9.
        View in: PubMed
      111. Takemoto S, Terasaki PI, Park MS, Clark BD. Effect of mismatching serologically defined residues on kidney transplant survival. Transplant Proc. 1992 Aug; 24(4):1266-8.
        View in: PubMed
      112. Takemoto S, Carnahan E, Terasaki PI. Beneficial effect of sharing six-antigen-matched cadaver kidneys in the United States. Transplant Proc. 1992 Aug; 24(4):1310-1.
        View in: PubMed
      113. Ogura K, Koyama H, Takemoto S, Terasaki PI, Busuttil RW. Significance of a positive crossmatch on outcome in human liver transplantation. Transplant Proc. 1992 Aug; 24(4):1465.
        View in: PubMed
      114. Takemoto S, Gjertson DW, Terasaki PI. HLA matching: a comparison of conventional and molecular approaches. Clin Transpl. 1992; 413-34.
        View in: PubMed
      115. Terasaki PI, Cecka JM, Gjertson DW, Cho Y, Takemoto S, Cohn M. A ten-year prediction for kidney transplant survival. Clin Transpl. 1992; 501-12.
        View in: PubMed
      116. Takemoto S, Terasaki PI. HLA peptide matching. Transplant Proc. 1991 Aug; 23(4):2039-42.
        View in: PubMed
      117. Gjertson DW, Terasaki PI, Takemoto S, Mickey MR. National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med. 1991 Apr 11; 324(15):1032-6.
        View in: PubMed
      118. Takemoto S, Carnahan E, Terasaki PI. A report of 504 six antigen-matched transplants. Transplant Proc. 1991 Feb; 23(1 Pt 2):1318-20.
        View in: PubMed
      119. Terasaki PI, Takemoto S, Park MS, Cecka JM, Mickey MR. Molecular HLA matching. Transplant Proc. 1991 Feb; 23(1 Pt 1):365-7.
        View in: PubMed
      120. Terasaki PI, Cecka JM, Cho Y, Takemoto S, Mickey MR. A report from the UNOS Scientific Renal Transplant Registry. Transplant Proc. 1991 Feb; 23(1 Pt 1):53-4.
        View in: PubMed
      121. Terasaki PI, Cecka JM, Lim E, Takemoto S, Cho Y, Gjertson D, Ogura K, Koyama H, Mitsuishi Y, Yuge J, et al. UCLA and UNOS Registries. Overview. Clin Transpl. 1991; 409-30.
        View in: PubMed
      122. Takemoto S, Terasaki PI. HLA epitopes and graft survival. Clin Transpl. 1991; 363-83.
        View in: PubMed
      123. Ishii T, Asuwa N, Masuda S, Ishikawa Y, Shimada K, Takemoto S. Earlobe crease and atherosclerosis. An autopsy study. J Am Geriatr Soc. 1990 Aug; 38(8):871-6.
        View in: PubMed
      124. Takemoto S, Terasaki P. HLA peptide matching. Clin Transpl. 1990; 497-513.
        View in: PubMed
      125. Takemoto S, Carnahan E, Terasaki PI. Report on 604 six-antigen-matched transplants. Clin Transpl. 1990; 485-95.
        View in: PubMed
      126. Takemoto S, Terasaki PI. A comparison of kidney transplant survival in white and black recipients. Transplant Proc. 1989 Dec; 21(6):3865-8.
        View in: PubMed
      127. Takemoto S, Terasaki PI. A report on 341 six-antigen matched transplants. Clin Transpl. 1989; 463-70.
        View in: PubMed
      128. Terasaki PI, Park MS, Takemoto S, Cecka JM, Clark B, Corcoran S, Cicciarelli J, Barbetti A, Yuge J, Carnahan E. Overview and epitope matching. Clin Transpl. 1989; 499-516.
        View in: PubMed
      129. Cecka JM, Corcoran S, Takemoto S, Cho Y, Mickey MR, Terasaki PI. The UNOS Scientific Renal Transplant Registry. Clin Transpl. 1989; 1-8.
        View in: PubMed
      130. Takemoto S, Terasaki PI. Donor age and recipient age. Clin Transpl. 1988; 345-56.
        View in: PubMed
      131. Terasaki PI, Cecka JM, Takemoto S, Yuge J, Mickey MR, Park MS, Iwaki Y, Cicciarelli J, Cho Y. Clinical transplants 1988. Overview. Clin Transpl. 1988; 409-34.
        View in: PubMed
      132. Iwaki Y, Lau M, Cook DJ, Takemoto S, Terasaki PI. Crossmatching with B and T cells and flow cytometry. Clin Transpl. 1986; 277-84.
        View in: PubMed
      133. Takahashi H, Iwaki Y, Terasaki PI, Okazaki H, Ishizaki M, Sekino H, Momma M, Takemoto S. Deliberate buffy-coat transfusions and the risk of antibody formation. Transplant Proc. 1982 Jun; 14(2):349-54.
        View in: PubMed
      Steven's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP